Total Payments
$9,000
2024 Payments
$3,716
Companies
28
Transactions
458
Medicare Patients
562
Medicare Billing
$36,560
Payment Breakdown by Category
Food & Beverage$8,279 (92.0%)
Other$542.22 (6.0%)
Education$177.84 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,279 | 452 | 92.0% |
| Long term medical supply or device loan | $542.22 | 2 | 6.0% |
| Education | $177.84 | 4 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,028 | 119 | $0 (2024) |
| Janssen Biotech, Inc. | $1,024 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $767.27 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $701.50 | 41 | $0 (2024) |
| PENTAX of America, Inc. | $542.22 | 2 | $0 (2024) |
| PFIZER INC. | $328.01 | 16 | $0 (2024) |
| Celgene Corporation | $322.59 | 21 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $310.21 | 19 | $0 (2024) |
| Ardelyx, Inc. | $308.09 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $294.84 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,716 | 170 | PENTAX of America, Inc. ($542.22) |
| 2023 | $2,623 | 130 | AbbVie Inc. ($630.02) |
| 2022 | $1,257 | 77 | ABBVIE INC. ($452.07) |
| 2021 | $1,403 | 81 | AbbVie Inc. ($532.81) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.03 | General |
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Immunology | ||||||
| 12/04/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $35.86 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: GI | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Immunology | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $29.47 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 212 | 265 | $34,624 | $14,860 |
| 2022 | 5 | 127 | 140 | $18,091 | $7,709 |
| 2021 | 5 | 223 | 271 | $29,954 | $13,991 |
Total Patients
562
Total Services
676
Medicare Billing
$36,560
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 98 | $12,285 | $5,320 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $7,300 | $2,821 | 38.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 68 | $3,944 | $2,094 | 53.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $4,960 | $1,920 | 38.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $3,720 | $1,522 | 40.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 23 | $2,415 | $1,184 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 45 | $5,223 | $2,205 | 42.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $3,348 | $1,598 | 47.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $3,212 | $1,437 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $3,930 | $1,426 | 36.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 41 | $2,378 | $1,044 | 43.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 74 | 78 | $14,508 | $6,490 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 49 | $4,979 | $2,865 | 57.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 81 | 114 | $6,612 | $2,779 | 42.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,250 | $1,123 | 49.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 15 | $1,605 | $733.88 | 45.7% |
About Michelle Addison
Michelle Addison is a Family healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2020. The National Provider Identifier (NPI) number assigned to this provider is 1043820251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Addison has received a total of $9,000 in payments from pharmaceutical and medical device companies, with $3,716 received in 2024. These payments were reported across 458 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,279).
As a Medicare-enrolled provider, Addison has provided services to 562 Medicare beneficiaries, totaling 676 services with total Medicare billing of $36,560. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Rochester, NY
- Active Since 08/03/2020
- Last Updated 08/23/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043820251
Products in Payments
- RINVOQ (Biological) $757.02
- STELARA (Biological) $693.21
- XIFAXAN (Drug) $656.65
- HUMIRA (Biological) $571.94
- VIDEO COLONOSCOPE (Device) $542.22
- ENTYVIO (Biological) $481.48
- ZEPOSIA (Drug) $322.59
- VOQUEZNA (Drug) $310.21
- IBSRELA (Drug) $308.09
- TREMFYA (Drug) $307.18
- DIFICID (Drug) $294.84
- XELJANZ (Drug) $284.91
- LINZESS (Drug) $270.59
- OMVOH (Drug) $250.51
- DUPIXENT (Biological) $248.42
- ZENPEP (Drug) $211.76
- Linzess (Drug) $195.54
- OCALIVA (Drug) $169.24
- SUCRAID (Drug) $163.12
- SKYRIZI (Biological) $162.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Rochester
Stephanie Bakker, Np, NP
Family — Payments: $41,839
Family $41,839
Dr. Sheldon Fields, Phd, Fnp, PHD, FNP
Family — Payments: $19,816
Family $19,816
Freda Hannafon, N.p, N.P
Family — Payments: $16,956
Family $16,956
Ms. Kelly Farrow, Np, NP
Family — Payments: $12,058
Family $12,058
Lucy Holmes
Family — Payments: $10,743
Family $10,743
Hillary Mcconnell, Fnp, FNP
Family — Payments: $9,398
Family $9,398